Background SARS-CoV-2 vaccines currently authorized for emergency use have been
highly successful in preventing infection and lessening disease severity. The vaccines …

Background The virus neutralization assay is a principal method to assess the efficacy of
antibodies in blocking viral entry. Due to biosafety handling requirements of viruses …

The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and …

Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic
cardiovascular complications up to 1 year after infection. Although the systemic inflammatory …

ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …

Monoclonal antibody therapy for the treatment of SARS-CoV-2 infection has been highly
successful in decreasing disease severity; however, the recent emergence of the heavily …

Highly transmissible SARS-CoV-2 variants identified in India and designated B. 1.617,
Kappa (B. 1.617. 1), Delta (B. 1.617. 2), B. 1.618, and B. 1.36. 29 contain spike mutations …

The SARS-CoV-2 lambda variant (lineage C. 37) was designated by the World Health
Organization as a variant of interest and is currently increasing in prevalence in South …

Laboratory testing has been a key tool in managing the SARS-CoV-2 global pandemic.
While rapid antigen and PCR testing has proven useful for diagnosing acute SARS-CoV-2 …

The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine effectiveness. Here, neutralizing antibody titers elicited by mRNA …